help button home button Am J Pathol Epitomics Buy 2 Antibodies Get 1 Free Special Offer
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Wibulswas, A.
Right arrow Articles by Kramer, I. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Wibulswas, A.
Right arrow Articles by Kramer, I. M.
(American Journal of Pathology. 2000;157:2037-2044.)
© 2000 American Society for Investigative Pathology

Regular Articles

The CD44v7/8 Epitope as a Target to Restrain Proliferation of Fibroblast-Like Synoviocytes in Rheumatoid Arthritis

Auragun Wibulswas*, Daniel Croft*, Ian Bacarese-Hamilton{dagger}, Peter McIntyre{ddagger}, Elisabeth Genot§ and IJsbrand M. Kramer*

From the Department of Pharmacology,*
University College, London; the Orthopedics Department,{dagger}
Whittington Hospital; Novartis Institute for Medical Sciences,{ddagger}
London; and the Department of Immunology,§
Hammersmith Hospital, London, United Kingdom

CD44 is a receptor for the glycosaminoglycan hyaluronan. It exists in a large range of isoforms because of variability in the pattern of glycosylation (both N- and O-linked) and of multiple splice variants. Human fibroblast-like synoviocytes derived from patients with rheumatoid arthritis express certain CD44 splice variants and we have investigated the functional implications of their expression. We found that the rate of proliferation of fibroblast-like synoviocytes expressing the CD44v7/8 epitope (average doubling time 55 hours) exceeds those obtained from the same synovial specimen but lacking this particular epitope (69 hours). Antibodies against CD44v7/8, but not against other exons, inhibit cell proliferation with concomitant induction of the cell cycle inhibitors GADD45, GADD153 and the cyclin-dependent protein-kinase inhibitors p21Waf/Cip. These data show that expression of CD44v7/8 contributes to the transformed phenotype of fibroblast-like synoviocytes. More importantly, they reveal the presence of a target that might be amenable to pharmacological intervention in the treatment of rheumatoid arthritis.




This article has been cited by other articles:


Home page
 J. Immunol.Home page
P. Huebener, T. Abou-Khamis, P. Zymek, M. Bujak, X. Ying, K. Chatila, S. Haudek, G. Thakker, and N. G. Frangogiannis
CD44 Is Critically Involved in Infarct Healing by Regulating the Inflammatory and Fibrotic Response
J. Immunol., February 15, 2008; 180(4): 2625 - 2633.
[Abstract] [Full Text] [PDF]

Home page
 Physiol. GenomicsHome page
C. Zer, G. Sachs, and J. M. Shin
Identification of genomic targets downstream of p38 mitogen-activated protein kinase pathway mediating tumor necrosis factor-{alpha} signaling
Physiol Genomics, October 19, 2007; 31(2): 343 - 351.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2000 by the American Society for Investigative Pathology.